These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 195767

  • 1. Ocular and systemic antiviral activity of vidarabine.
    Pavan-Langston D, Hess F.
    Compr Ther; 1977 Jul; 3(7):42-8. PubMed ID: 195767
    [No Abstract] [Full Text] [Related]

  • 2. Therapy for human herpesvirus infections. A perspective.
    Whitley RJ.
    Ala J Med Sci; 1985 Apr; 22(2):193-207. PubMed ID: 2988359
    [No Abstract] [Full Text] [Related]

  • 3. Antiviral agents.
    Hermans PE, Cockerill FR.
    Mayo Clin Proc; 1983 Apr; 58(4):217-22. PubMed ID: 6339831
    [Abstract] [Full Text] [Related]

  • 4. Use of vidarabine in Ophthalmology: a review.
    Pavan-Langston D.
    Ann Ophthalmol; 1977 Jul; 9(7):835-9. PubMed ID: 332031
    [No Abstract] [Full Text] [Related]

  • 5. [Antiviral chemotherapy].
    Eggers HJ.
    Monatsschr Kinderheilkd; 1986 Mar; 134(3):122-9. PubMed ID: 3010086
    [Abstract] [Full Text] [Related]

  • 6. Ara AMP- a highly soluble new antiviral drug.
    Pavan-Langston D, North RD, Geary PA.
    Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
    [Abstract] [Full Text] [Related]

  • 7. [Arabinosyladenine in ophthalmology (author's transl)].
    Colin J.
    J Fr Ophtalmol; 1981 May; 4(6-7):525-30. PubMed ID: 7028853
    [Abstract] [Full Text] [Related]

  • 8. Current status of antiviral chemotherapy.
    Whitley RJ, Alford CA.
    South Med J; 1978 Sep; 71(9):1134-40. PubMed ID: 210524
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current trends in therapy of ocular herpes simplex: experimental and clinical studies.
    Pavan-Langston D.
    Adv Ophthalmol; 1979 Sep; 38():82-8. PubMed ID: 93409
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of human herpesvirus infections with special reference to encephalitis.
    Whitley RJ.
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():57-74. PubMed ID: 6092319
    [No Abstract] [Full Text] [Related]

  • 16. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
    Falcon MG, Jones BR.
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():83-9. PubMed ID: 863807
    [No Abstract] [Full Text] [Related]

  • 17. Anti-herpes activity of adenine arabinoside monophosphate.
    Trobe JD, Centifanto Y, Zam ZS, Varnell E, Kaufman HE.
    Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
    [Abstract] [Full Text] [Related]

  • 18. [Present state of antiviral therapy (author's transl)].
    ter Meulen V.
    Monatsschr Kinderheilkd (1902); 1979 Jun; 127(6):367-71. PubMed ID: 379620
    [Abstract] [Full Text] [Related]

  • 19. Treatment of herpes simplex keratitis with idoxuridine and vidarabine: a double-blind study.
    Chin GN.
    Ann Ophthalmol; 1978 Sep; 10(9):1171-4. PubMed ID: 367239
    [Abstract] [Full Text] [Related]

  • 20. [Adenine-arabinoside in the treatment of idu-resistant herpes simplex keratitis (author's transl)].
    Colin J, Baikoff G, Chastel C, Renard G.
    J Fr Ophtalmol; 1979 Mar; 2(3):205-7. PubMed ID: 156754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.